- Home
- AKRO vs CRTO Comparison
AKRO vs CRTO Comparison
Compare AKRO & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AKRO | CRTO |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 1.1B |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | AKRO | CRTO |
|---|---|---|
| Price | $54.65 | $19.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | ★ $73.56 | $38.67 |
| AVG Volume (30 Days) | ★ 2.4M | 537.0K |
| Earning Date | 11-07-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.79 |
| EPS | N/A | ★ 3.00 |
| Revenue | N/A | ★ $1,956,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.42 |
| P/E Ratio | ★ N/A | $6.62 |
| Revenue Growth | N/A | ★ 0.53 |
| 52 Week Low | $21.34 | $19.00 |
| 52 Week High | $58.40 | $47.27 |
Technical Indicators
Market Signals| Indicator | AKRO | CRTO |
|---|---|---|
| Relative Strength Index (RSI) | 68.63 | 40.95 |
| Support Level | $54.30 | $19.69 |
| Resistance Level | $54.70 | $21.39 |
| Average True Range (ATR) | 0.17 | 0.91 |
| MACD | -0.10 | -0.00 |
| Stochastic Oscillator | 71.07 | 17.94 |
Price Performance
Historical ComparisonAbout AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.